{
  "docId": "019de075-7c2e-7510-9012-23bac78506e5",
  "docSlug": "6afb08ad9ecba2144545352067526476",
  "documentTitle": "Bluejay | Investor Presentation Deck | 20 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 20,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "team_bio",
  "function": "other",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7c2e-7510-9012-23bac78506e5/16",
  "deckHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5",
  "deckJsonHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5.json",
  "deckAnchorHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.08,
        "x": 0.34,
        "y": 0.72
      },
      "kind": "image",
      "text": "East Boston Savings Bank",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ac4f887-10c3-4f00-b89c-956efef7819f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.08,
        "x": 0.57,
        "y": 0.735
      },
      "kind": "image",
      "text": "University of Texas",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "410480d3-13ae-4584-8adf-1596d372281d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.09,
        "x": 0.1,
        "y": 0.74
      },
      "kind": "image",
      "text": "IMPATH",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "730f6cdc-1534-4299-a461-f44e3bad90df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.12,
        "x": 0.78,
        "y": 0.745
      },
      "kind": "image",
      "text": "Brigham and Women's Hospital",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96c038b3-fa8b-4bad-a87e-78dcf26ac964",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.22,
        "x": 0.04,
        "y": 0.235
      },
      "kind": "paragraph",
      "text": "Indranil “Neil” Dey, CEO and Co-founder. Involved in introducing Her2neu test for Herceptin. Ph.D. in Biochemistry (UNESCO fellow) from BRC, Hungary, MBA (Fulbright Scholar) from Cambridge University, UK.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "017d9a6b-1556-4d9e-9bdc-28461dfdf4c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.22,
        "x": 0.5,
        "y": 0.235
      },
      "kind": "paragraph",
      "text": "Jason Cook, Chief Technology Officer. Responsible for product development and manufacturing operations. 15+ years in POC/ diagnostics product development. Ph.D. in Biomedical Engineering, University of Texas at Austin.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9bdbe191-3fb2-4247-bacf-940db9ecae1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.22,
        "x": 0.27,
        "y": 0.235
      },
      "kind": "paragraph",
      "text": "Kenneth Fisher, Chief Financial Officer. Responsible for finance, investor relations, accounting and administrative operations. CPA; BA, Business Administration, Isenberg School of Management, University of Massachusetts at Amherst.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b432376c-3c86-4e21-bd75-0a4d3814d371",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.22,
        "x": 0.73,
        "y": 0.235
      },
      "kind": "paragraph",
      "text": "Mark Feinberg, Chief Medical Advisor. Responsible for clinical development programs and strategic medical leadership. Associate Professor, Harvard Medical School/Cardiovascular, Brigham & Women’s; Medical College of Pennsylvania.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fec0d92f-1077-4df6-a7d3-0f063cbac97e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.835,
        "x": 0.038,
        "y": 0.085
      },
      "kind": "title",
      "text": "Management & Advisors: Leadership, Diagnostic & Product Launch Expertise",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4d473f2-5096-4838-b81b-4f409dcfba3f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "323a99f9-b560-4fa5-afa7-e808d1a00f37",
      "evidence": "paragraph/paragraph: Kenneth Fisher, Chief Financial Officer. Responsible for finance, investor relations, accounting and administrative operations.",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c2e62651-f3f1-4333-88f5-3a258ba00fce",
      "evidence": "The deck implicitly discusses the cost of inaction by emphasizing the life-threatening nature of sepsis and the benefits of rapid diagnosis.",
      "position": 0,
      "objective": "Highlight the cost of not acting quickly in sepsis diagnosis and treatment.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}